Efficient Self-Assembled MicroRNA Delivery System Consisting of Cholesterol-Conjugated MicroRNA and PEGylated Polycationic Polymer for Tumor Treatment

2019 ◽  
Vol 2 (5) ◽  
pp. 2219-2228 ◽  
Author(s):  
Byeonggeol Mun ◽  
Eunji Jang ◽  
Seungmin Han ◽  
Hye Young Son ◽  
Yuna Choi ◽  
...  
FEBS Journal ◽  
2012 ◽  
Vol 279 (7) ◽  
pp. 1198-1208 ◽  
Author(s):  
Yang Pan ◽  
Yuan Zhang ◽  
Tingting Jia ◽  
Kuo Zhang ◽  
Jinming Li ◽  
...  

2020 ◽  
Vol 3 (11) ◽  
pp. 7831-7839
Author(s):  
Xiao-He Ren ◽  
Xiao-Yan He ◽  
Bo-Ya Liu ◽  
Chang Xu ◽  
Si-Xue Cheng

2021 ◽  
Author(s):  
husun qian ◽  
Yixin Fu ◽  
Minkang Guo ◽  
Wu Yang ◽  
Dian Zhang ◽  
...  

Abstract There is increasing interest in depleting or repolarizing tumor-associated macrophages (TAMs) to generate a pro-inflammatory effect. However, TAMs usually display an immunosuppressive M2-like phenotype in tumor microenvironment. Apparently, developing a macrophage targeting delivery system with immunomodulatory agents is urgent. In the study, an efficient siRNAs and CpG ODNs delivery system (CpG-siRNA-tFNA) was prepared with nucleic acid stepwise self-assembled. The tFNA composed of CpG ODNs and siRNAs showed a higher stability and an enhanced cellular uptake efficiency. Moreover, the CpG-siRNA-tFNA effectively reprogrammed TAMs toward M1 phenotype polarization with increased pro-inflammatory cytokines secretion and NF-κB signal pathways activation, which triggers dramatical antitumor immune responses. Hence, we have developed an efficient and reliable TAM-targeted therapeutic with immunomodulatory agents for for clinical applications.


2020 ◽  
Vol 9 (9) ◽  
pp. 5380-5389
Author(s):  
Chunmin Li ◽  
Xin Li ◽  
Fengsheng Li ◽  
Dawei Wang ◽  
Jin Wang ◽  
...  

2019 ◽  
Vol 2 (11) ◽  
pp. 4737-4746
Author(s):  
Tengfei Wang ◽  
Shanni Hong ◽  
Yu Luo ◽  
Haiyin Lv ◽  
Ye Zhang ◽  
...  

2020 ◽  
Vol 8 (16) ◽  
pp. 3527-3533 ◽  
Author(s):  
Lairong Ding ◽  
Junwei Li ◽  
Changrong Wu ◽  
Feng Yan ◽  
Xuemei Li ◽  
...  

A novel RNA-triple-helix hydrogel for treatment of triple negative breast cancers (TNBCs) by incorporating RNA-triple-helix and siRNA duplexes of CXCR4 into the same RNA nanoparticles was developed, without the synthetic polycationic reagents.


RSC Advances ◽  
2018 ◽  
Vol 8 (55) ◽  
pp. 31581-31587 ◽  
Author(s):  
Lin Wang ◽  
Xuefeng Shi ◽  
Jian Zhang ◽  
Yuejun Zhu ◽  
Jinben Wang

Supramolecular hydrogel, AGC16/NTS, was used to encapsulate hydrophobic drug curcumin (Cur), constructing a pH-responsive drug delivery system; the uptake of released Cur by cancer cells also occurred.


Sign in / Sign up

Export Citation Format

Share Document